Fcpm Iii Services B.V. Dyne Therapeutics, Inc. Call Options Transaction History
Fcpm Iii Services B.V.
- $678 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding DYN
# of Institutions
201Shares Held
106MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$288 Million37.7% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$265 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$229 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$217 Million3.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$169 Million0.0% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.86B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...